Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
Super-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral system and rheology of lipiodol. Although SSLB-T...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Gastrointestinal Intervention
2020-01-01
|
Series: | International Journal of Gastrointestinal Intervention |
Subjects: | |
Online Access: | https://doi.org/10.18528/ijgii190025 |
id |
doaj-7ea25dcce00f4d76b00757bbf714b796 |
---|---|
record_format |
Article |
spelling |
doaj-7ea25dcce00f4d76b00757bbf714b7962020-11-25T02:21:35ZengSociety of Gastrointestinal InterventionInternational Journal of Gastrointestinal Intervention2636-00122020-01-0191131810.18528/ijgii19002510.18528/ijgii190025Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the rolesToshiyuki Irie0Nobuyuki Takahashi1Sodai Hoshiai2Department of Radiology, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, JapanDepartment of Radiology, Tsukuba Memorial Hospital, Tsukuba, JapanDepartment of Radiology, Faculty of Medicine, University of Tsukuba, Tsukuba, JapanSuper-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral system and rheology of lipiodol. Although SSLB-TACE is thought to be a promising technique, randomized prospective controlled trials to compare local control rates with conventional super-selective lipiodol (c-TACE) are still lacking. Another problem for SSLB-TACE is change of TACE candidates by development of radiofrequency ablation (RFA) technology. Patients with limited number of small nodules are good candidates for both SSLB-TACE and c-TACE, but these are also good candidates for RFA. Because higher priority is given to RFA, TACE is usually indicated for patients with 4 or more nodules, with large nodule(s), and/or with proximal Glisson attaching nodule(s). However, these cases are known as TACE-refractory, and the chance to perform SSLBTACE or c-TACE would be markedly decreased in institutions where RFA is aggressively performed. In the past, paradigm shift from non-selective TACE to super-selective TACE occurred, and the goal of SSLB-TACE and c-TACE is prolonged complete remission of the treated nodules while sacrificing small volume of liver parenchyma. But another TACE technique, aiming treatment of wide region (hemi-lobe or more) and effective tumor volume reduction while minimizing liver parenchymal damage, is mandatory in RFA era. For this purpose, we developed a new balloon-occluded TACE without using lipiodol; alternate infusion of cisplatin solution and sparse gelatin slurry was repeated under balloon-occlusion (RAIB-TACE) until stasis of gelatin slurry in proximal hepatic arteries was seen. However, not only RFA but also recent development of molecular targeted drugs strongly influences on the indication and the aim of TACE. The goal and technique of TACE should be properly selected in each era, in each institution, and for each patient.https://doi.org/10.18528/ijgii190025balloon occlusionchemoembolizationtherapeutichepatocellular carcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Toshiyuki Irie Nobuyuki Takahashi Sodai Hoshiai |
spellingShingle |
Toshiyuki Irie Nobuyuki Takahashi Sodai Hoshiai Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles International Journal of Gastrointestinal Intervention balloon occlusion chemoembolization therapeutic hepatocellular carcinoma |
author_facet |
Toshiyuki Irie Nobuyuki Takahashi Sodai Hoshiai |
author_sort |
Toshiyuki Irie |
title |
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles |
title_short |
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles |
title_full |
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles |
title_fullStr |
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles |
title_full_unstemmed |
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles |
title_sort |
balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: history, background, and the roles |
publisher |
Society of Gastrointestinal Intervention |
series |
International Journal of Gastrointestinal Intervention |
issn |
2636-0012 |
publishDate |
2020-01-01 |
description |
Super-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral system and rheology of lipiodol. Although SSLB-TACE is thought to be a promising technique, randomized prospective controlled trials to compare local control rates with conventional super-selective lipiodol (c-TACE) are still lacking. Another problem for SSLB-TACE is change of TACE candidates by development of radiofrequency ablation (RFA) technology. Patients with limited number of small nodules are good candidates for both SSLB-TACE and c-TACE, but these are also good candidates for RFA. Because higher priority is given to RFA, TACE is usually indicated for patients with 4 or more nodules, with large nodule(s), and/or with proximal Glisson attaching nodule(s). However, these cases are known as TACE-refractory, and the chance to perform SSLBTACE or c-TACE would be markedly decreased in institutions where RFA is aggressively performed. In the past, paradigm shift from non-selective TACE to super-selective TACE occurred, and the goal of SSLB-TACE and c-TACE is prolonged complete remission of the treated nodules while sacrificing small volume of liver parenchyma. But another TACE technique, aiming treatment of wide region (hemi-lobe or more) and effective tumor volume reduction while minimizing liver parenchymal damage, is mandatory in RFA era. For this purpose, we developed a new balloon-occluded TACE without using lipiodol; alternate infusion of cisplatin solution and sparse gelatin slurry was repeated under balloon-occlusion (RAIB-TACE) until stasis of gelatin slurry in proximal hepatic arteries was seen. However, not only RFA but also recent development of molecular targeted drugs strongly influences on the indication and the aim of TACE. The goal and technique of TACE should be properly selected in each era, in each institution, and for each patient. |
topic |
balloon occlusion chemoembolization therapeutic hepatocellular carcinoma |
url |
https://doi.org/10.18528/ijgii190025 |
work_keys_str_mv |
AT toshiyukiirie balloonoccludedtransarterialchemoembolizationforhepatocellularcarcinomahistorybackgroundandtheroles AT nobuyukitakahashi balloonoccludedtransarterialchemoembolizationforhepatocellularcarcinomahistorybackgroundandtheroles AT sodaihoshiai balloonoccludedtransarterialchemoembolizationforhepatocellularcarcinomahistorybackgroundandtheroles |
_version_ |
1724865321072852992 |